YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
SHANGHAI, Oct. 7, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received a Gold medal from EcoVadis for the third consecutive year, reflecting…
Investing.com -- Bernstein has identified several China-based biopharmaceutical companies positioned to benefit from evolving drug development capabilities, with a focus on integrated platforms and service providers that support AI-enabled…
Company Logo Stricter quality rules, complex biologics and outsourcing are driving demand for impurity isolation, synthesis and analytics, creating opportunities for specialized labs and CROs. Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "Ph…
Company Logo Opportunities center on AI-enabled decentralized trials, therapeutic specialization, global patient recruitment, regulatory support, real-world evidence and integrated partnerships. Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "…
Company Logo Pharma R&D outsourcing is rising as CROs use AI, genomics and advanced screening to cut costs, accelerate discovery, improve compliance and support targeted therapies. Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Drug Discovery…
Company Logo Demand for outsourced pharmacokinetics services is rising, driven by AI, advanced bioanalysis, personalized medicine, biologics and complex global trials. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharmacokinetics Services -…
Company Logo Stricter safety rules, drug innovation and CRO outsourcing drive demand, while imaging, CRISPR and data analytics improve testing and reduce animal use. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "In Vivo Toxicology - Global S…
Company Logo Pharma companies are expanding drug discovery outsourcing to cut costs, access CRO expertise and AI tools, speed pipelines, manage regulatory complexity, and advance targeted therapies. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE)…
Company Logo Stricter safety rules and drug innovation are boosting demand, while high-throughput screening, predictive analytics, biomarkers, and non-animal methods create new opportunities. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Tox…
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy. T…
Company Logo Demand is rising for faster, accurate ADME-Tox testing, driven by complex biologics, tighter regulation, personalized medicine, and adoption of high-throughput, in vitro and in silico methods. Dublin, Sept. 22, 2026 (GLOBE NEW…
WuXi AppTec Longer-lasting activity is a defining feature of the next generation of oligonucleotide medicines, with chemical modifications, conjugation, and tissue-targeting strategies helping extend pharmacological activity from days towa…
WuXi AppTec Beyond-liver delivery is becoming the next major frontier for oligonucleotide medicines, with growing efforts to reach muscle, the central nervous system, lung, immune cells and tumors. No single delivery technology is likely t…
* WuXi AppTec (WUXAY [https://seekingalpha.com/symbol/WUXAY]) has announced the distribution of its 2026 interim cash dividend totaling RMB 1.51 billion. * The latest distribution represents a notable increase from the company’s inaugural…
SHANGHAI, Aug. 30, 2026 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announces the distribution of its 2026…
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it. Often, t…
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy. T…
By David Shepardson and Alexandra Alper WASHINGTON, Aug 7 (Reuters) - A federal judge on Friday barred the U.S. Defense Department from including Chinese biotechnology company WuXi AppTec Co on a list of companies believed to support Beij…
SHANGHAI, Aug. 3, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced financial results for the first h…
SHANGHAI, July 21, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announced it has been named in the FTSE4Good Index Series for the fourth consecuti…
WuXi AppTec Design of targeted protein degraders is more than target degradation. Linker architecture, molecular flexibility, solubility, permeability, synthesis, purification, and formulation can all influence whether a candidate can adva…
WuXi AppTec Structural complexity in modern small molecules is reshaping what drug development partners must deliver from discovery through commercial supply. Targeted protein degraders, covalent agents, and a new wave of kinase inhibitors…
June 11 (Reuters) - WuXi AppTec said on Thursday that it has filed a complaint at the United States District Court for the District of Columbia against the Department of Defense for including the company in a list linked to …
SHANGHAI, May 17, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has been selected for the 2026 Dow Jones Best-in-Class World Index (DJ BIC World In…
Company Logo The clinical trials market is forecasted to experience strong growth, expanding from $92.63 billion to $158.1 billion between 2025 and 2034, driven by rising pharmaceutical and biotechnology R&D, chronic disease prevalence, an…
Company Logo Key prospects lie in R&D innovation, scaling manufacturing, and CDMO outsourcing, with a strong focus on cell therapies and gene-based interventions Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Middle East and Africa Cell a…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The central fair value estimate for WuXi AppTec has shifted from CN…
Total Revenue Reached RMB 12.44 Billion; Revenue from Continuing Operations Up 39.4% YoY Adjusted Non-IFRS Net Profit Up 71.7% YoY to RMB 4.60 Billion Backlog for Continuing Operations Up 23.6% YoY to RMB 59.77 Billion SHANGHAI, April 27,…
2025 Total Revenue Reached RMB 45.46 Billion; Revenue from Continuing Operations Up 21.4% YoY Adjusted Non-IFRS Net Profit Up 41.3% YoY to RMB 14.96 Billion Backlog for Continuing Operations Up 28.8% YoY to RMB 58.00 billion SHANGHAI, Marc…
Company Logo The PDX model market is projected to grow from USD 0.37 billion in 2025 to USD 0.66 billion by 2030, with a CAGR of 12.5%. This growth is fueled by rising cancer incidences and demand for preclinical models replicating human t…
Company Logo The Clinical Trials industry is set to achieve significant growth, projecting a value of US$ 99.25 Billion by 2033 from US$ 61.93 Billion in 2025, at a CAGR of 6.07%. This surge is driven by an increased demand for innovative…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Adeno Associated Virus Vector Manufacturing Market size & share revenue was valued at…
SHANGHAI, Jan. 18, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the "A List" for leadership in corp…
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today issued a Positive Profit Alert for the full…
Hong Kong stocks rose for a third day on Friday, sending the benchmark gauge to its longest winning streak in three weeks, after softer US inflation data bolstered the case for monetary easing and allayed concerns about frothy valuations o…
This article first appeared on GuruFocus. The narrative around Chinese tech just picked up a sharper edge. Bloomberg reporting indicates the Pentagon has concluded that Alibaba Group Holding (NYSE:BABA), Baidu Inc (BIDU), and BYD Co (BYDDF…